期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

温水坐浴联合中西药治疗Ⅲ型前列腺炎临床观察 被引量：6

下载PDF
导出
摘要 目的观察温水坐浴联合前列舒通、盐酸坦洛新治疗Ⅲ型前列腺炎的临床疗效。方法将216例Ⅲ型前列腺炎患者随机分为2组,实验组112例予以温水坐浴联合口服前列舒通、盐酸坦洛新治疗,对照组104例单纯给予口服前列舒通及盐酸坦洛新治疗。2组均以4周为1个疗程,1个疗程后统计治疗前后慢性前列腺炎症状(NIH-CPSI)评分和临床疗效。结果 2组治疗后NIH-CPSI评分均显著改善(P均<0.05),且2组比较有显著性差异(P<0.05);2组疗效比较有显著性差异(P<0.05)。结论温水坐浴联合前列舒通、盐酸坦洛新治疗Ⅲ型前列腺炎具有较好的疗效。
作者 武斌 陆向东 李建华 苏燕胜 陈勇
机构地区 解放军第
出处 《现代中西医结合杂志》 CAS 2013年第15期1638-1639,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 慢性前列腺炎 中西药结合疗法 温水坐浴
分类号 R697.33 [医药卫生—泌尿科学]
  • 相关文献

参考文献8

  • 1Forrest JB,Schmidt S. Interstitial cystitis,chronic nonbactefial pros- tatitis and chronic pelvic pain syndrome in men:a common and fre- quently identical clinical entity[J]. J Urol,2004,172:2561 -2562.
  • 2Geppetti P, Nassini R, Materazzi S,et al. The concept of neurogenic inflammation[ J]. BJU Int,2008,101 ( Supple 3 ) :2 - 6.
  • 3Nicke C. Prostatitis: lessons from the 20 century[ J]. Br J Urol, 2000,85(2) :179 - 185.
  • 4沈学成,洪理,饶贤才,宋波,周占松.Ⅲ型前列腺炎患者前列腺液中纳米细菌的培养和形态学鉴定[J].中华泌尿外科杂志,2008,29(8):512-515. 被引量：11
  • 5武立新,梁朝朝,唐智国,郝宗耀,刘骋,郭清奎.前列腺液白细胞计数与临床症状的相关分析[J].中华泌尿外科杂志,2006,27(3):194-196. 被引量：45
  • 6Cornel EB, Van Haarst EP,Scharsberg RW,et al. The effect of bio- feedback physical therapy in-men with chronic pelvic pain syndrome type Ⅲ [ J]. European Urology,2005,47:607 - 611.
  • 7沈映君.中药药理学[M].北京:人民卫生出版社,2002.255-256.
  • 8Cheah PY,Liong ML,Yuen KH,et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trail [ J ]. J Urol,2003,169 ( 2 ) : 592 - 596.

二级参考文献10

  • 1WENYu,LIYong-guo,YANGZhu-lin,WANGXue-jun,WEIHong,LIUWei,MIAOXiong-ying,WANGQun-wei,HUANGSheng-fu,YANGJing,E.OlaviKajander,NevaCiftcioglu.Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis[J].Chinese Medical Journal,2005(5):421-424. 被引量：15
  • 2Wesselmann U.Neurogenic inflammation and chronic pelvic pain.World J Urol,2001,19 :180-185.
  • 3Litwin MS,McNaughton-Collins M,Fowler FJ Jr,et al.The National Institutes of Health chronic prostatitis symptom index:development and validation of a new outcome measure.Chronic Prostatitis Collaborative Research Network.J Urol,1999,162:369-375.
  • 4Ludwig M,Schroeder-Printzen I,Ludecke G,et al.Comparison of expressed prostatic secretions with urine after prostatic massage-a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome.Urology,2000,55:175-177.
  • 5Schaeffer AJ,Knauss JS,Landis R,et al.Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis:The National Institutes of Health Chronic Prostatitis Cohort Study.American Urological Association,Inc.2002,168:1048-1053.
  • 6Potts JM.Chronic pelvic pain syndrome:a non-prostatocentric perspective.World J Urol,2003,21:54-56.
  • 7Nickel JC,Alexander RB,Schaeffer AJ,et al.Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.J Urol.2003,170:818-822.
  • 8True LD,Berger RE,Rothman I,et al.Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome:a prospective biopsy study.J Urol,1999,162:2014-2018.
  • 9Propert K J,Alexander RB,Nickel JC,et al.Design of a multi-center randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.Urology,2002,59:870-876.
  • 10李永国,文宇,杨竹林,魏红,刘威,谭爱玲,吴晓瑛,王群伟,黄生福,Kajander EO,Ciftcioglu N.胆汁纳米细菌的培养与鉴定[J].中华医学杂志,2002,82(22):1557-1560. 被引量：17

共引文献153

同被引文献48

  • 1宛传丹,周金保,宋逸萍,邹学军,马月琴.前列腺炎病原体流行病学与耐药趋势分析[J].中华男科学杂志,2013,19(10):912-917. 被引量：16
  • 2王圣林,王少波.退变突出的颈椎间盘周围炎症反应及其临床意义[J].中国脊柱脊髓杂志,2005,15(9):562-564. 被引量：16
  • 3李新忠,苑庆龄.青年颈椎病的发病及其诊治[J].中医正骨,1996,8(6):15-16. 被引量：35
  • 4张敏建,邓庶民,郭军,商学军,常德贵,李宏军,周少虎,高兆旺.慢性前列腺炎中西医结合诊疗指南(试行版)[J].中国中西医结合杂志,2007,27(11):1052-1056. 被引量：231
  • 5Inci M, Davarci M, Motor, S. et al.Anti-inflammatory and antioxidant activity of thymoquinone in a rat model of acute bacterial prostatitis[J].Human and Experimental Tox- icology, 2013, 32(4):354-361.
  • 6Nishikawa G, Ikawa K,Nakamura, K. et al.Prostatic pene- tration of meropenem in humans, and dosage consider- ations for prostatitis based on a site-specific pharmacoki- netic/pharmacodynamic evaluation[J].Int J Antimicrob, 2013,41(3)-.267-271.
  • 7Choi H,Sim JS,Park JY,et al.Assessment of Tamsulosin 0.2 mg for Symptomatic Bladder Outlet Obstruction Seconda- ry to Benign Prostatic Enlargement:Data from a Korean Multicenter Cross-Sectional Study[J].Urol Int,2015,95(1):50-55.
  • 8Sidaway P.Stones:Now the drugs don't work:tamsulosin is ineffective as medical expulsive therapy[J]. Nat Rev Urol,2015,12(7):357.
  • 9Nazir J,Heemstra L,van Engen A,et al.Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostat- ic hyperplasia[J].BMC Urol,2015,9(15):41.
  • 10Chung SJ,Jung SI,Ryu JW,et al.The preventive effect of tamsulosin on voiding dysfunction after prostate biopsy:a prospective,open-label,observational study[J].Int Urol Nephrol,2015,47(5):711-715.

引证文献6

二级引证文献13

现代中西医结合杂志
2013年 第15期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部